Susquehanna International Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110M | Buy |
375,200
+27,400
| +8% | +$9.01M | 0.01% | 770 |
|
|
2025
Q4 | $122M | Sell |
347,800
-79,700
| -19% | -$26.9M | 0.01% | 762 |
|
|
2025
Q3 | $138M | Buy |
427,500
+87,100
| +26% | +$27.1M | 0.02% | 704 |
|
|
2025
Q2 | $132M | Buy |
340,400
+51,600
| +18% | +$20.8M | 0.02% | 611 |
|
|
2025
Q1 | $126M | Buy |
288,800
+13,100
| +5% | +$5.26M | 0.02% | 556 |
|
|
2024
Q4 | $102M | Buy |
275,700
+105,800
| +62% | +$44.3M | 0.02% | 701 |
|
|
2024
Q3 | $88.3M | Buy |
169,900
+33,700
| +25% | +$18M | 0.02% | 709 |
|
|
2024
Q2 | $73.8M | Buy |
136,200
+8,100
| +6% | +$4.28M | 0.01% | 748 |
|
|
2024
Q1 | $66.4M | Sell |
128,100
-164,200
| -56% | -$81.7M | 0.01% | 865 |
|
|
2023
Q4 | $138M | Buy |
292,300
+11,200
| +4% | +$5.18M | 0.03% | 549 |
|
|
2023
Q3 | $122M | Sell |
281,100
-8,300
| -3% | -$3.76M | 0.03% | 529 |
|
|
2023
Q2 | $129M | Sell |
289,400
-11,800
| -4% | -$5.44M | 0.03% | 498 |
|
|
2023
Q1 | $138M | Buy |
301,200
+50,900
| +20% | +$24.2M | 0.03% | 476 |
|
|
2022
Q4 | $128M | Sell |
250,300
-71,900
| -22% | -$36.5M | 0.03% | 458 |
|
|
2022
Q3 | $146M | Buy |
322,200
+95,100
| +42% | +$45.5M | 0.04% | 386 |
|
|
2022
Q2 | $110M | Buy |
227,100
+17,800
| +9% | +$8.81M | 0.03% | 494 |
|
|
2022
Q1 | $103M | Sell |
209,300
-16,100
| -7% | -$7.36M | 0.02% | 648 |
|
|
2021
Q4 | $104M | Sell |
225,400
-315,200
| -58% | -$133M | 0.02% | 695 |
|
|
2021
Q3 | $202M | Buy |
540,600
+141,100
| +35% | +$53.6M | 0.03% | 515 |
|
|
2021
Q2 | $153M | Sell |
399,500
-152,700
| -28% | -$58.4M | 0.02% | 619 |
|
|
2021
Q1 | $198M | Sell |
552,200
-67,000
| -11% | -$21.5M | 0.03% | 448 |
|
|
2020
Q4 | $199M | Sell |
619,200
-24,600
| -4% | -$7.55M | 0.03% | 420 |
|
|
2020
Q3 | $173M | Sell |
643,800
-50,100
| -7% | -$13.5M | 0.03% | 381 |
|
|
2020
Q2 | $182M | Buy |
693,900
+34,800
| +5% | +$9.28M | 0.04% | 321 |
|
|
2020
Q1 | $150M | Buy |
659,100
+83,100
| +14% | +$22.6M | 0.05% | 282 |
|
|
2019
Q4 | $174M | Sell |
576,000
-190,200
| -25% | -$52.3M | 0.05% | 314 |
|
|
2019
Q3 | $184M | Buy |
766,200
+268,400
| +54% | +$73.5M | 0.06% | 261 |
|
|
2019
Q2 | $140M | Buy |
497,800
+145,300
| +41% | +$39.7M | 0.05% | 314 |
|
|
2019
Q1 | $101M | Buy |
352,500
+133,000
| +61% | +$38.5M | 0.04% | 372 |
|
|
2018
Q4 | $57.6M | Sell |
219,500
-20,400
| -9% | -$5.61M | 0.02% | 553 |
|
|
2018
Q3 | $65.7M | Buy |
239,900
+78,400
| +49% | +$20.4M | 0.02% | 574 |
|
|
2018
Q2 | $38.4M | Sell |
161,500
-42,100
| -21% | -$9.75M | 0.01% | 824 |
|
|
2018
Q1 | $44.7M | Sell |
203,600
-253,200
| -55% | -$59.5M | 0.02% | 713 |
|
|
2017
Q4 | $103M | Sell |
456,800
-60,200
| -12% | -$12.8M | 0.04% | 413 |
|
|
2017
Q3 | $98.2M | Buy |
517,000
+99,000
| +24% | +$18.8M | 0.04% | 387 |
|
|
2017
Q2 | $78.6M | Sell |
418,000
-82,600
| -17% | -$14.8M | 0.03% | 420 |
|
|
2017
Q1 | $82.8M | Buy |
500,600
+700
| +0.1% | +$111K | 0.04% | 390 |
|
|
2016
Q4 | $71.9M | Sell |
499,900
-74,300
| -13% | -$9.95M | 0.04% | 422 |
|
|
2016
Q3 | $72M | Buy |
574,200
+111,000
| +24% | +$14.3M | 0.03% | 408 |
|
|
2016
Q2 | $60.8M | Buy |
463,200
+121,400
| +36% | +$16.6M | 0.03% | 448 |
|
|
2016
Q1 | $47.5M | Buy |
341,800
+65,700
| +24% | +$8.78M | 0.03% | 545 |
|
|
2015
Q4 | $38.5M | Sell |
276,100
-172,400
| -38% | -$23.7M | 0.02% | 739 |
|
|
2015
Q3 | $62.8M | Sell |
448,500
-469,500
| -51% | -$70.6M | 0.03% | 516 |
|
|
2015
Q2 | $151M | Buy |
918,000
+527,600
| +135% | +$84.3M | 0.06% | 271 |
|
|
2015
Q1 | $60.3M | Sell |
390,400
-271,700
| -41% | -$38.7M | 0.03% | 551 |
|
|
2014
Q4 | $83.2M | Sell |
662,100
-91,000
| -12% | -$11.2M | 0.03% | 482 |
|
|
2014
Q3 | $90.1M | Sell |
753,100
-2,200
| -0.3% | -$252K | 0.03% | 448 |
|
|
2014
Q2 | $81.3M | Buy |
755,300
+29,200
| +4% | +$3.01M | 0.04% | 451 |
|
|
2014
Q1 | $72.3M | Sell |
726,100
-85,600
| -11% | -$7.74M | 0.03% | 468 |
|
|
2013
Q4 | $75M | Buy |
811,700
+126,200
| +18% | +$11.2M | 0.03% | 465 |
|
|
2013
Q3 | $57.3M | Buy |
685,500
+86,400
| +14% | +$7.4M | 0.03% | 539 |
|
|
2013
Q2 | $49M | Buy |
+599,100
| New | +$44.8M | 0.03% | 567 |
|
Other funds holding ELV
VCM
VPM
Susquehanna International Group's ELV Position: Q1 2026 in Review
Susquehanna International Group increased its Elevance Health (ELV) stake by 17% in Q1 2026, buying an estimated $7.29M and bringing the position to 150,529 shares worth $44.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1391.
Susquehanna International Group first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $92.8M in Q2 2023. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Susquehanna International Group held 150,529 shares of Elevance Health worth $44.1M as of Q1 2026.
- Susquehanna International Group bought 22,176 Elevance Health shares in Q1 2026, an estimated $7.29M.
- Elevance Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1391 holding.
- Susquehanna International Group first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's Elevance Health position peaked at $92.8M in Q2 2023.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.